Abstract:Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that is more common in females. Despite its high global incidence, the disease mechanism is still unclear and therapeutic options remain limited. The sexual dimorphism in IBS incidence suggests that sex steroids play a role in disease onset and symptoms severity. This review considers sex steroids and their involvement in IBS symptoms and the underlying disease mechanisms. Estrogens and androgens play important regulatory roles in IBS sym… Show more
“…As some neurological disorders including IBS and autism demonstrate sex bias in incidence and severity (222) (261), sexually dimorphic effects of steroids (particularly sex hormones) has been suggested as a possible etiology. Neuroactive hormone abundance under normal physiological conditions is different in females and males.…”
Section: Sex Steroidsmentioning
confidence: 99%
“…This could be due to estrogen potentiating TRPV1 channel activity (270), which contributes to pain sensation and is upregulated in IBS (4). Furthermore, sex steroids regulate the serotonergic system (222), which could also explain why sex dependence is evident in alterations of the serotonergic system in IBS, which is another signal associated with pain (168). Despite the lack of consistency in IBSassociated microbiome signatures, the gut microbiota could mediate the effect of steroids in IBS pathogenesis.…”
Section: Irritable Bowel Syndromementioning
confidence: 99%
“…Considerable evidence over recent years also connects the gut microbiota to this signaling conduit, extending the commonly used terminology to the "microbiota-gut-brain axis" (144). Different signaling molecules, including steroids are involved in these complex communications (222). Steroids are lipid-derived molecules that generally contain four fused rings of carbon atoms with a chemical structure that plays an important role in a wide range of biological functions, including reproduction, metabolism and immune responses.…”
The intricate connection between central and enteric nervous systems is well established with emerging evidence linking gut microbiota function as a significant new contributor to gut-brain axis signaling. Several microbial signals contribute to altered gut-brain communications, with steroids representing an important biological class that impacts central and enteric nervous system function. Neuroactive steroids contribute pathologically to neurological disorders, including dementia and depression, by modulating the activity of neuroreceptors. However, limited information is available on the influence of neuroactive steroids on the enteric nervous system and gastrointestinal function. In this review, we outline how steroids can modulate enteric nervous system function by focusing on their influence on different receptors that are present in the intestine in health and disease. We also highlight the potential role of the gut microbiota in modulating neuroactive steroid signaling along the gut-brain axis.
“…As some neurological disorders including IBS and autism demonstrate sex bias in incidence and severity (222) (261), sexually dimorphic effects of steroids (particularly sex hormones) has been suggested as a possible etiology. Neuroactive hormone abundance under normal physiological conditions is different in females and males.…”
Section: Sex Steroidsmentioning
confidence: 99%
“…This could be due to estrogen potentiating TRPV1 channel activity (270), which contributes to pain sensation and is upregulated in IBS (4). Furthermore, sex steroids regulate the serotonergic system (222), which could also explain why sex dependence is evident in alterations of the serotonergic system in IBS, which is another signal associated with pain (168). Despite the lack of consistency in IBSassociated microbiome signatures, the gut microbiota could mediate the effect of steroids in IBS pathogenesis.…”
Section: Irritable Bowel Syndromementioning
confidence: 99%
“…Considerable evidence over recent years also connects the gut microbiota to this signaling conduit, extending the commonly used terminology to the "microbiota-gut-brain axis" (144). Different signaling molecules, including steroids are involved in these complex communications (222). Steroids are lipid-derived molecules that generally contain four fused rings of carbon atoms with a chemical structure that plays an important role in a wide range of biological functions, including reproduction, metabolism and immune responses.…”
The intricate connection between central and enteric nervous systems is well established with emerging evidence linking gut microbiota function as a significant new contributor to gut-brain axis signaling. Several microbial signals contribute to altered gut-brain communications, with steroids representing an important biological class that impacts central and enteric nervous system function. Neuroactive steroids contribute pathologically to neurological disorders, including dementia and depression, by modulating the activity of neuroreceptors. However, limited information is available on the influence of neuroactive steroids on the enteric nervous system and gastrointestinal function. In this review, we outline how steroids can modulate enteric nervous system function by focusing on their influence on different receptors that are present in the intestine in health and disease. We also highlight the potential role of the gut microbiota in modulating neuroactive steroid signaling along the gut-brain axis.
“…Clinical observations have found that women tend to have slower gastrointestinal (GI) transit and are more prone to constipation than men. However, previous studies have obtained contradictory findings regarding the effect of the various sex hormones on GI motility (25)(26)(27). A recent study based on female dihydrotestosterone (DHT)-treated PCOS rats found lower maximal colon muscle contractility in response to acetylcholine stimulation in DHT-treated rats than in untreated rats (28).…”
Background/ObjectivesPolycystic ovary syndrome (PCOS) and irritable bowel syndrome (IBS) share similar clinical and psychosocial features. We aimed to investigate the clinical characteristics of IBS in women with PCOS, and its relationship with obesity, metabolic and hormonal profiles, as well as sleep and psychiatric disorders.Subjects/MethodsThis is a cross-sectional case-control study of 431 untreated women with PCOS and 259 healthy volunteers. All participants were assessed with a comprehensive clinical evaluation and two questionnaires: the Athens Insomnia Scale (AIS) and the Brief Symptom Rating Scale (BSRS-5). IBS was diagnosed using the Rome III criteria. Obesity was defined as a BMI ≥30 kg/m2. Anthropometric measurements, metabolic, hormonal profiles, and psychosocial morbidities were compared.ResultsWomen with PCOS were more likely to have IBS (10.7% vs 5.8%, p=0.029) and obesity (29% vs 4%, p<0.001) than healthy volunteers. Mixed-type IBS (IBS-M) was the most common subtype (74%) among patients with PCOS and IBS. There was a higher prevalence of psychiatric morbidities (total BSRS-5 score ≥10) in women with PCOS than in healthy women (11.4% vs 3.5%, p<0.001). Women with PCOS and IBS were more likely to have sleep difficulties (67.4% vs 30.9%, p<0.001) and psychiatric morbidities (21.7% vs 10.1%, p=0.019) than those without IBS. Anthropometrics, metabolic and hormonal profiles were similar between PCOS women with and without IBS. Among women with PCOS, those with both IBS and obesity had the highest risk of developing sleep difficulties (odds ratio: 5.91; 95% confidence interval: 1.77–19.77) and psychiatric distress (odds ratio: 4.39; 95% confidence interval: 1.26–15.29) than those without.ConclusionWomen with PCOS have increased IBS, obesity, sleep and psychiatric disturbances. The presence of IBS in PCOS women is associated with sleep and psychiatric disorders. The coexistence of obesity and IBS exacerbates sleep difficulties and psychiatric distress. Screening and management of IBS and obesity might be warranted to improve sleep and psychiatric disturbances in women with PCOS.
“…These immune responses could also underpin differences in COVID-19 vaccine efficacy. Sex steroids are known to regulate the gut microbiota ( Manosso et al, 2021 , So and Savidge, 2021 ) and thus could mediate vaccine efficacy through the gut microbiota. As such studies are warranted that would investigate the role of the gut microbiota in gender differences in COVID-19 vaccine efficacy.…”
Section: Intestinal Dysbiosis Linking Risk Factors To Inefficacy Of Covid-19 Vaccinesmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.